Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Johnson

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Experimental and Molecular Pathology|December 1, 1971
Subacute sclerosing panencephalitis (SSPE) agent in hamsters. I. Acute giant cell encephalitis in newborn animalsK P Johnson, D P Byington
Archives of Neurology|April 1, 1973
Relapsing idiopathic polyneuritis during pregnancy. Immunological aspects and literature reviewD J Novak, K P Johnson
The Journal of Infectious Diseases|July 1, 1972
Experimental subacute sclerosing panencephalitis in the hamster: correlation of age with chronic inclusion-cell encephalitisD P Byington, K P Johnson
Clinical Immunology and Immunopathology|November 1, 1985
Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2R L Hirsch, K P Johnson
Neurology|April 1, 1985
The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosisR L Hirsch, K P Johnson
Journal of Virological Methods|September 1, 1981
A mathematical model for the hemolysin of measles virusD R Carrigan, K P Johnson
Infection and Immunity|April 1, 1976
Vaccinia virus meningitis in mice after intracerebral inoculationA H Ginsberg, K P Johnson
Lancet (London, England)|February 16, 1999
Interferon beta treatment for multiple sclerosisK P Johnson, H S Panitch
Journal of Interferon Research|April 1, 1986
The effects of long-term administration of recombinant alpha-2 interferon on lymphocyte subsets, proliferation, and suppressor cell function in multiple sclerosisR L Hirsch, K P Johnson
The New England Journal of Medicine|December 31, 1970
Aqueductal stenosis and hydrocephalus after mumps encephalitisG D Timmons, K P Johnson
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Experimental and Molecular Pathology|December 1, 1971
Subacute sclerosing panencephalitis (SSPE) agent in hamsters. I. Acute giant cell encephalitis in newborn animalsK P Johnson, D P Byington
Archives of Neurology|April 1, 1973
Relapsing idiopathic polyneuritis during pregnancy. Immunological aspects and literature reviewD J Novak, K P Johnson
The Journal of Infectious Diseases|July 1, 1972
Experimental subacute sclerosing panencephalitis in the hamster: correlation of age with chronic inclusion-cell encephalitisD P Byington, K P Johnson
Clinical Immunology and Immunopathology|November 1, 1985
Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2R L Hirsch, K P Johnson
Neurology|April 1, 1985
The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosisR L Hirsch, K P Johnson
Journal of Virological Methods|September 1, 1981
A mathematical model for the hemolysin of measles virusD R Carrigan, K P Johnson
Infection and Immunity|April 1, 1976
Vaccinia virus meningitis in mice after intracerebral inoculationA H Ginsberg, K P Johnson
Lancet (London, England)|February 16, 1999
Interferon beta treatment for multiple sclerosisK P Johnson, H S Panitch
Journal of Interferon Research|April 1, 1986
The effects of long-term administration of recombinant alpha-2 interferon on lymphocyte subsets, proliferation, and suppressor cell function in multiple sclerosisR L Hirsch, K P Johnson
The New England Journal of Medicine|December 31, 1970
Aqueductal stenosis and hydrocephalus after mumps encephalitisG D Timmons, K P Johnson
Pageof 15